HIV Vaccines Research

HIV is a very complex, highly changeable virus, which makes speedy development of a successful preventive HIV vaccine very difficult, but not impossible.  It also takes many years to conduct the research, including the careful clinical testing that will lead to a safe and effective vaccine.

Researchers from around the world have been working for more than two decades to create a vaccine that will protect people against HIV infection. NIAID supports the HIV Vaccine Trials Network (HVTN), an international collaboration of scientists and educators searching for an effective and safe HIV vaccine.

  • Current Advancements
  • Support
  • Updates
  • New developments
  • Age acceleration effects due to HIV infection
  • Long-term nonprogressor
  • Microbicides for sexually transmitted diseases
  • Stem cell transplantation
  • Preclinical HIV Research
  • HIV Transmission/Diversity
  • Basic HIV Vaccine Discovery
  • HIV Vaccine Designs and Strategies
  • NIAID HIV Vaccine Research
  • Preclinical HIV Research
  • Clinical HIV Vaccine Research
  • Translational HIV Vaccine Research
  • Modified vaccinia Ankara:Vaccinia virus

Related Conference of HIV Vaccines Research

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
September 09-10, 2024

7th International Conference on Vaccines and Immunology

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

HIV Vaccines Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in